References
- Finnegan L. Treatment issues for opioid-dependent women during the perinatal period. J Psychoactive Drugs 1991; 23: 191–201
- Eap C B, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone. Clin Pharmacokinet 2002; 41: 1153–1193
- Jarvis M AE, Wu-Pong S, Kniseley J S, Schnoll S H. Alterations in methadone metabolism during late pregnancy. J Addict Dis 1999; 18: 51–61
- Wolff K, Boys A, Rostami-Hodjegan A, Hay A, Raistrick D. Changes to methadone clearance during pregnancy. Eur J Clin Pharmacol 2005; 61: 763–768
- Pond S M, Kreek M J, Tong T G, Raghunath J, Benowitz N L. Altered methadone pharmacokinetics in methadone-maintained pregnant women. J Pharmacol Exp Ther 1985; 233: 1–6
- Hoegerman G, Schnoll S. Narcotic use in pregnancy. Clin Perinatol 1991; 18: 51–76
- DePetrillo P, Rice J. Methadone dosing and pregnancy: impact on program compliance. Int J Addict 1995; 30: 207–217
- Swift R, Dudley M, DePetrillo P, Camara P, Griffiths W. Altered methadone pharmacokinetics in pregnancy: implications for dosing. J Subst Abuse 1989; 1: 453–460
- Jansson L, Elko A, DiPietro J. Fetal response to maternal methadone administration. Obstet Gynecol 2005; 193: 611–617
- Wouldes T, Roberts A, Pryor J, Bagnall C, Gunn T. The effect of methadone treatment on the quantity and quality of human fetal movement. Neurotoxicol Teratol 2004; 26: 23–34
- Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy: effects and management. Obstet Gynecol Clin North Am 1998; 25: 139–151
- Wittman B, Segal S. A comparison of the effects of the single- and split-dose methadone administration on the fetus: ultrasound evaluation. Int J Addict 1991; 26: 213–218
- Jansson L, Svikis D, Lee J, Paluzzi P, Rutigliano P, Hackerman F. Pregnancy and addiction: a comprehensive care model. J Subst Abuse Treat 1996; 13: 321–329
- Kreek M. Plasma and urine levels of methadone. NY State J Med 1973; 23: 2773–2777
- Handelsman L, Cochrane K, Aronson M, Ness R, Rubinstein K, Kanof P. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987; 13: 293–308
- DiPietro J, Costigan K, Pressman E. Fetal movement detection: comparison of the toitu actograph with ultrasound from 20 weeks gestation. J Matern Fetal Med 1999; 8: 237–242
- Porges S. Respiratory sinus arrhythmia: physiological basis, quantitative methods, and clinical implications. Cardiorespiratory and Cardiosomatic Psychophysiology, P Grossman, K Janssen, D Vaitl. Plenum, New York, NY 1986; 101–115
- Timor-Tritsch I E, Dierker L J, Zador I, Hertz R H, Rosen M G. Fetal movements associated with fetal heart rate accelerations and decelerations. Am J Obstet Gynecol 1978; 131: 276–280
- DiPietro J, Hodgson D, Costigan K, Hilton S, Johnson T. Development of fetal movement-fetal heart rate coupling from 20 weeks through term. Early Hum Dev 1996; 44: 139–151
- Jansson L M, DiPietro J A, Elko A, Velez M. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates. J Matern Fetal Neonatal Med 2007; 20: 677–685
- Blinick G, Inturrisi C E, Jerez E, Wallach R C. Methadone assays in pregnant women and progeny. Am J Obstet Gynecol 1975; 121: 617–621
- Jansson L, Choo R, Harrow C, Velez M, Schroeder J R, Lowe R, Huestis M A. Concentrations of methadone in breast milk and plasma in the immediate perinatal period. J Hum Lact 2007; 23: 184–190
- McCarthy J, Leamon M, Parr M, Anania B. Hi-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Obstet Gynecol 2005; 193: 606–610